Portola Pharmaceuticals Inc Asset Turnover Ratio (PTLA), as of first quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Portola Pharmaceuticals inc   (NASDAQ: PTLA)
 

Portola Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Portola Pharmaceuticals Inc 's asset turnover ratio, the ratio that measures the ability of Portola Pharmaceuticals Inc 's assets to generate revenue, sequentially decreased to 0.24 in the first quarter (Mar 31 2020), which does not come as a surprise, as the Portola Pharmaceuticals Inc continue to experience difficult business climate.

Within sector 58 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2020, to 1366, from total ranking in the fourth quarter 2019 at 2762.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTLA Asset Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Asset Change 39.49 % 56.72 % 35.2 % -28.5 % -25.38 %
Y / Y Revenue Change 19.04 % 91.19 % 159.57 % 608.65 % 233.67 %
Asset Turnover Ratio (TTM) 0.24 0.25 0.25 0.21 0.13
PTLA's Total Ranking # 1366 # 2762 # 1317 # 1532 # 697
Seq. Asset Change -10.71 % -0.66 % 57.49 % -0.14 % 0.32 %
Seq. Revenue Change -9.78 % -20.52 % 29.46 % 28.22 % 44.91 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 59
Healthcare Sector # 115
Overall Market # 1366

Asset Turnover Ratio Statistics
High Average Low
583.59 61.45 5.52
(Sep 30 2015)   (Dec 31 2014)




PTLA Company Profile • Back to PTLA Efficiency Comparisons • Compare PTLA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2020 Assets at quarter ending Mar 31 2020
Surmodics Inc   0.65 $ 100.598  Millions$ 155.203  Millions
Heartbeam Inc   0.65 $ 448.159  Millions$ 691.618  Millions
Apollo Endosurgery inc   0.64 $ 48.220  Millions$ 75.048  Millions
Baxter International Inc   0.64 $ 11,532.000  Millions$ 18,027.750  Millions
Davita Inc   0.64 $ 11,486.604  Millions$ 18,072.621  Millions
Luminex Corporation  0.63 $ 342.654  Millions$ 539.807  Millions
Syneos Health Inc   0.63 $ 4,720.164  Millions$ 7,454.595  Millions
Chembio Diagnostics Inc   0.63 $ 32.485  Millions$ 51.475  Millions
Quest Diagnostics Inc  0.63 $ 7,657.000  Millions$ 12,167.750  Millions
Emmaus Life Sciences Inc   0.63 $ 29.246  Millions$ 46.570  Millions
Quidelortho Corp  0.63 $ 561.575  Millions$ 897.833  Millions
Hill rom Holdings Inc   0.63 $ 2,917.800  Millions$ 4,665.025  Millions
Meridian Bioscience Inc   0.63 $ 204.003  Millions$ 326.279  Millions
Sanuwave Health Inc   0.62 $ 1.499  Millions$ 2.414  Millions
Stablecoin Development Corporation  0.62 $ 7.000  Millions$ 11.292  Millions
Avantor Inc   0.62 $ 6,079.200  Millions$ 9,835.075  Millions
Camp4 Therapeutics Corporation  0.62 $ 366.107  Millions$ 592.338  Millions
Atrion Corporation  0.61 $ 157.046  Millions$ 256.991  Millions
Iradimed Corporation  0.61 $ 38.757  Millions$ 63.628  Millions
Neuronetics Inc   0.61 $ 61.404  Millions$ 100.883  Millions
Vertex Pharmaceuticals Inc  0.61 $ 4,819.493  Millions$ 7,939.923  Millions
Bioadaptives Inc   0.60 $ 0.013  Millions$ 0.022  Millions
Cantel Medical Corp   0.60 $ 1,022.153  Millions$ 1,694.921  Millions
Sangui Biotech International Inc  0.60 $ 0.046  Millions$ 0.077  Millions
Nuvasive Inc  0.60 $ 1,153.175  Millions$ 1,937.743  Millions
Logicmark Inc  0.59 $ 16.700  Millions$ 28.166  Millions
Eli Lilly And Company  0.59 $ 23,087.100  Millions$ 39,237.100  Millions
Aveo Pharmaceuticals Inc   0.59 $ 27.968  Millions$ 47.642  Millions
Crh Medical Corporation  0.58 $ 116.721  Millions$ 201.024  Millions
Steris Plc  0.58 $ 3,030.895  Millions$ 5,260.339  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.